SCHEMBL487320

SCHEMBL487320

C=C(C#N)C(=O)OC(C)OC

nearest known ligand 0.47

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26911834 0.92 ALDH1A1 (0.44) ALDH1A1TSHR
SCHEMBL26911395 0.91 ALDH1A1 (0.43) ALDH1A1TSHR
SCHEMBL29078239 0.91 ALDH1A1 (0.43) ALDH1A1TSHR
SCHEMBL4889903 0.82 ALDH1A1 (0.46) ALDH1A1TSHR
SCHEMBL8371104 0.82 TSHR (0.46) ALDH1A1TSHR
SCHEMBL4895741 0.81 ALDH1A1 (0.42) ALDH1A1TSHR
SCHEMBL230496 0.81 ALDH1A1 (0.52) ALDH1A1TSHR
SCHEMBL11802497 0.81 ALDH1A1 (0.44) ALDH1A1TSHR
SCHEMBL28162516 0.81 ALDH1A1 (0.44) ALDH1A1TSHR
SCHEMBL462000 0.79 ALDH1A1 (0.56) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 674 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260112694-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES Anthro Energy, Inc. (US) 2026-04-23 US claimed
US-20260088310-A1 SHAPED BATTERY CELL AND METHOD OF MANUFACTURE Anthro Energy, Inc. (US) 2026-03-26 US claimed
US-20260041183-A1 ADHESIVE FOR COSMETIC ARTICLE AND METHOD OF FORMING FULLER H B CO (US) 2026-02-12 US claimed
EP-3579890-B1 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FEMASYS INC (US) 2025-06-18 EP claimed
WO-2025119862-A1 COMPOSITION COMPRISING N-HEPTYLCYANOACRYLATE BOSTIK SA (FR) 2025-06-12 WO claimed
CN-120025745-A Strippable nail glue instant adhesive and preparation method thereof 浙江久而久化学有限公司 2025-05-23 CN claimed
US-20250149631-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES Anthro Energy, Inc. (US) 2025-05-08 US claimed
WO-2025091014-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES Anthro Energy, Inc. (US) 2025-05-01 WO claimed
CN-116209729-B Thickener for cyanoacrylate-based adhesives 旭化成株式会社 2025-04-08 CN claimed
CN-118924940-A Super-flexibility skin-adhesive biological glue and preparation process thereof 浙江派菲特新材料科技有限公司 2024-11-12 CN claimed
US-20030082116-A1 Adhesive compositions containing dual function stabilizers and active agents CLOSURE MEDICAL CORPORATION (US) 2003-05-01 US claimed
US-6512023-B1 An adhesive composition includes a polymerizable adhesive monomer, at least one vapor phase stabilizer, and at least one liquid phase stabilizer. The combination of at least one vapor phase stabilizer and at least one liquid phase CLOSURE MEDICAL CORPORATION 2003-01-28 US claimed
US-20020055573-A1 Stabilized monomer adhesive compositions CLOSURE MEDICAL CORPORATION (US) 2002-05-09 US claimed
WO-2002020069-A2 ANTIOXIDANT ENRICHED ADHESIVE COMPOSITIONS AND STORAGE CONTAINERS THEREFOR CLOSURE MEDICAL CORPORATION (US) 2002-03-14 WO claimed
WO-2002009784-A1 ACRYLIC-BASED ADHESIVE COMPOSITION UNIVERSIDAD DE ALICANTE (ES) 2002-02-07 WO claimed
EP-0965623-A1 Stabilized monomer adhesive compositions Closure Medical Corporation (US) 1999-12-22 EP claimed
US-5536799-A DIPENTAERYTHRITOL POLYACRYLATE TOAGOSEI CO., LTD. (JP) 1996-07-16 US claimed
US-5135784-A Wrapping web container and cutter for cutting wrapping web AYAKO OKUMURA (JP) 1992-08-04 US claimed
EP-0163757-A1 Adhesive composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-12-11 EP claimed
US-4496685-A COMPRISING ALPHA CYANOACRYLATE MONOMER AND A PHOSPHAZENE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-01-29 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260088310-A1 SHAPED BATTERY CELL AND METHOD OF MANUFACTURE FTO, DCX, TET1 ALDH1A1 2522/4885TSHR 1842/4885
US-20260041183-A1 ADHESIVE FOR COSMETIC ARTICLE AND METHOD OF FORMING KRT18, CDH1, CFL1 ALDH1A1 556/4885TSHR 3226/4885
US-20030082116-A1 Adhesive compositions containing dual function stabilizers and active agents TLN1, PTK2, ILK ALDH1A1 812/4885TSHR 4697/4885
US-20260112694-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES PARG, PUF60, PHOSPHO1 ALDH1A1 3548/4885TSHR 2412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.